COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade
Titel:
COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade
Auteur:
Hansen, Kyle Kumar, Sandeep Logronio, Kathryn Whelan, Sarah Qurashi, Samir Cheng, Hsin-Yuan Drake, Andrew Tang, Margaret Wall, Patrick Bernados, David Leung, Ling Ophir, Eran Alteber, Zoya Cojocaru, Gady Galperin, Moran Frenkel, Masha White, Mark Hunter, John Liang, Spencer C. Kotturi, Maya F.